Snowball logo
logo
RVLP

RVLPQ

$0.000001$0.00  (0%)
Estimate
EPS
-0.07
Beta
41.601
About the company
Ticker
RVLPQ
ISIN
IE00BF2HDL56
Country
Other
Sector (GICS)
Healthcare
RVL Pharmaceuticals plc operates as a specialty pharmaceutical company in the United States, Argentina, and Hungary. It focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. It is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.

Frequently asked questions

What sector does RVLPQ (RVLPQ) operate in?

RVLPQ belongs to the Healthcare sector and operates in the Biotechnology industry.

What is RVLPQ (RVLPQ) current stock price?

As of the latest data, RVLPQ stock price is $0.00, with a previous close of $0.00.

What is RVLPQ (RVLPQ) current market capitalization?

RVLPQ market cap is approximately 111.41.

What is RVLPQ (RVLPQ) Earnings Per Share (EPS)?

The trailing EPS is -$0.07.

Does RVLPQ (RVLPQ) pay dividends?

No. RVLPQ does not pay a dividend.

What is RVLPQ (RVLPQ) beta (volatility) score?

RVLPQ has a beta of 41.601, indicating very high volatility compared to the market.